Fundraising Fox
Alpha-9 Oncology
Vancouver, CA · 39 employees on LinkedIn · 17 known investors
Find your way into Alpha-9 Oncology
Sign up to find every way you can get introduced to Alpha-9 Oncology
- Your email: who you already know at Alpha-9 Oncology, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Alpha-9 Oncology team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Alpha-9 Oncology develops radiopharmaceuticals for cancer treatment, with a portfolio of molecules in clinical and preclinical development. The company serves patients with cancer through novel drug candidates advancing in clinical trials.
Founders & leadership
Investors · 17
How we know: a16z's portfolio · Not right? Tell us
How we know: Ascenta Capital's portfolio page · pharmaceutical-technology.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: Frazier Life Sciences's portfolio page · press coverage · Not right? Tell us
.png)
How we know: General Catalyst's portfolio page · press coverage · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Lightspeed Venture Partners's portfolio page · pharmaceutical-technology.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Longitude Capital's portfolio page · press coverage · the VCSheet dataset · Not right? Tell us
How we know: Lumira Ventures's portfolio page · funding news · press coverage · Not right? Tell us
How we know: Nextech Invest's portfolio page · a partner's Signal profile · press coverage · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: RA Capital's portfolio page · pharmaceutical-technology.com · Not right? Tell us
How we know: Samsara BioCapital's portfolio page · pharmaceutical-technology.com · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: press coverage · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$175M disclosed across 1 round · 2024
- $175Mseries COct 2024 · 3 sources
Ascenta Capital (lead), Lightspeed Venture Partners (lead), a16z Bio + Health, abrdn plc, Biotechnology Value Fund, Frazier Life Sciences, Janus Henderson Investors, RA Capital Management, Samsara BioCapital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 2
Companies working in the same space as Alpha-9 Oncology.
In the news
Frequently asked questions
- What does Alpha-9 Oncology do?
- Alpha-9 Oncology develops radiopharmaceuticals for cancer treatment, with a portfolio of molecules in clinical and preclinical development. The company serves patients with cancer through novel drug candidates advancing in clinical trials.
- Who founded Alpha-9 Oncology?
- Alpha-9 Oncology was founded by François Bénard, Kuo-Shyan Lin, David Perrin.
- Who are Alpha-9 Oncology's investors?
- Alpha-9 Oncology's investors include Andreessen Horowitz, Ascenta Capital, Delos Capital, Frazier Life Sciences, General Catalyst, Lightspeed Venture Partners, Longitude Capital, Lumira Ventures and 8 more.
- How much funding has Alpha-9 Oncology raised?
- Alpha-9 Oncology has disclosed $175M raised across 1 round.
- Where is Alpha-9 Oncology headquartered?
- Alpha-9 Oncology is headquartered in Vancouver, CA.